Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Akso Health Group ADR (AHG)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: AHG (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -33.71% | Avg. Invested days 30 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 479.35M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta -0.67 | 52 Weeks Range 0.74 - 1.98 | Updated Date 06/29/2025 |
52 Weeks Range 0.74 - 1.98 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.08 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -77.92% | Operating Margin (TTM) -7.8% |
Management Effectiveness
Return on Assets (TTM) -3.73% | Return on Equity (TTM) -6.41% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 395956654 | Price to Sales(TTM) 56.7 |
Enterprise Value 395956654 | Price to Sales(TTM) 56.7 | ||
Enterprise Value to Revenue 46.83 | Enterprise Value to EBITDA -0.39 | Shares Outstanding 396160992 | Shares Floating 714403226 |
Shares Outstanding 396160992 | Shares Floating 714403226 | ||
Percent Insiders - | Percent Institutions 0.07 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Akso Health Group ADR
Company Overview
History and Background
Akso Health Group ADR was founded with a focus on providing health and wellness solutions. Details on its exact founding year and early milestones are not readily available in standard financial data sources. The company has evolved to offer a range of health-related products and services.
Core Business Areas
- Online Pharmacy and Healthcare Services: Akso Health Group ADR provides online pharmacy services, telemedicine consultations, and access to various healthcare products through its digital platform. This segment focuses on convenient and accessible healthcare solutions.
Leadership and Structure
Information about Akso Health Group ADR's leadership team and organizational structure is not extensively detailed in readily available financial databases. Generally, it would include a CEO, CFO, and other key executives overseeing different operational areas.
Top Products and Market Share
Key Offerings
- Online Pharmacy Services: Akso Health Group ADR offers prescription medication and over-the-counter products through its online platform. Market share data for specific products are not readily available, but they compete with other online pharmacies and traditional brick-and-mortar stores such as CVS and Walgreens. Revenue data is not widely published. Competitors: CVS (CVS), Walgreens Boots Alliance (WBA), Amazon Pharmacy (AMZN)
Market Dynamics
Industry Overview
The healthcare industry, particularly online pharmacies and telemedicine, is experiencing significant growth due to increasing demand for convenient and accessible healthcare services. The industry is highly competitive and subject to evolving regulations.
Positioning
Akso Health Group ADR aims to carve out a niche by providing specialized online pharmacy and healthcare services. Its competitive advantage could stem from proprietary technology, strategic partnerships, or customer service excellence.
Total Addressable Market (TAM)
The global digital health market is estimated to reach hundreds of billions of dollars, with a significant portion attributable to online pharmacies and telemedicine services. Akso Health Group ADR is positioned to capture a share of this TAM through its online platform.
Upturn SWOT Analysis
Strengths
- Online platform for convenient access to healthcare
- Potential for expansion into underserved markets
- Partnerships with healthcare providers
Weaknesses
- Limited brand recognition compared to established players
- Reliance on regulatory approvals and compliance
- Customer acquisition costs in a competitive market
Opportunities
- Growing demand for telemedicine and online pharmacies
- Strategic acquisitions to expand service offerings
- Partnerships with insurance companies and healthcare systems
Threats
- Intense competition from larger online pharmacies
- Changes in healthcare regulations
- Data security and privacy concerns
Competitors and Market Share
Key Competitors
- CVS
- WBA
- AMZN
Competitive Landscape
Akso Health Group ADR faces significant competition from larger, more established online pharmacies. Its ability to differentiate itself through specialized services, strong customer service, or innovative technology is crucial for its success.
Growth Trajectory and Initiatives
Historical Growth: Assessment of historical growth trends requires time-series financial data.
Future Projections: Future growth projections are not readily available without analyst estimates.
Recent Initiatives: Information on recent strategic initiatives is not readily available.
Summary
Akso Health Group ADR operates in the growing online pharmacy and telemedicine market. It has the potential to capitalize on the increasing demand for accessible healthcare, but faces stiff competition. The company needs to focus on building brand recognition, expanding its service offerings, and managing regulatory compliance effectively. Financial data accessibility is limited, impacting a full financial performance analysis, meaning a stronger understanding of the numbers would be useful.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Website
- Market Research Reports
- Public Financial Databases
Disclaimers:
The information provided is based on publicly available data and should not be considered financial advice. Market share estimates are approximate and may vary depending on the source. Financial metrics may not be entirely accurate due to limited data availability.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Akso Health Group ADR
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2006-12-28 | CEO & Chairwoman of the Board Ms. Yilin Wang | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 9 | Website https://www.ahgtop.com |
Full time employees 9 | Website https://www.ahgtop.com | ||
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscope. In addition, it is involved in the provision of health treatment services. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.